Equine anti-thymocyte globulin/Antilymphocyte immunoglobulin (horse)

Specification Drug Information Related Products

Cat#:	THP-0107
Product Name:	Equine anti-thymocyte globulin/Antilymphocyte immunoglobulin (horse)
Description:	Equine anti-thymocyte globulin is composed of purified gamma globulin containing primarily IgG against human thymus lymphocytes. It is formed by inoculating a horse with an antigen (human thymoyctes) which then induces the horse immune system's B-lymphocytes to produce IgG immunoglobulins specific for that antigen. The result is polyclonal IgG that is then purified from the horse's serum to produce a usable product that can be used for immunosuppression.
Sequences:	Not Available
Species:	Horse
Molecular Weight:	Not Available
Cas No:	Not Available
Formula:	Not Available
Endotoxin Level:	<0.001 EU per 1 μg of the peptide by the LAL method
Biological Activity:	50 mg/1mL

Drug Name:	Antilymphocyte immunoglobulin (horse)
Applications:	For prevention of renal transplant rejection and for the treatment of aplastic anemia.
Examples of Clinical Use:	Renal transplant rejection and aplastic anemia
Pharmacodynamics:	Not Available
Mechanism of action:	Not Available
Affected organisms:	Not Available